Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News Merck to acquire Imago BioSciences to expand blood disorder drugs portfolio Pharma giant Merck will acquire Imago BioSciences, a Nasdaq-listed clinical stage biopharmaceutical company, for a price of $36… byRaghuram KadariNovember 23, 2022